send mail to firstname.lastname@example.org mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
Please verify your mobile number
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Refer & Earn
My Abhipedia Earning
Kindly Login to view your earning
Researchers from University of Helsinki have developed a molecule, that can inactivate the coronavirus spike protein. It also offers effective short-term protection against the coronavirus.
About TriSb92 Molecule
How was TriSb92 developed?
The TriSb92 molecule was developed on the basis of an entirely new technical solution developed in Finland to target biological drugs. This solution was utilized for inhibiting the functioning of spike protein on SARS-CoV-2 virus surface. When this inhibitory effect of TriSb92 molecule is targeted to a site of coronavirus spike protein (common to all variants of virus) makes it possible to effectively inhibit the ability of all the variants including Omicron.
Significance of the TriSb92
In the study, TriSb92 was able to prevent the spread of SARS, which threatened us in early 2000s. Thus, it can be assumed that, future variants of SARS-CoV-2 or even entirely new coronaviruses are susceptible to it. In future, this molecule could serve as kind of biological protection against coronavirus infection, which is sprayed on the mucous membranes.
By: Brijesh Kumar ProfileResourcesReport error
Access to prime resources